← Leaderboards
Martyn Darby
Affinergy ,Inc
$22,135,337
Attributed
$22,135,337
Total exposure
24
Grants
24
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.7M · FY2008–24$5M$3.8M$2.5M$1.3M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$22,135,337 · 24
By mechanism
R44$18,458,696 · 11
R43$3,676,641 · 13
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseSpecificityPeptidesAffinityPhage DisplayTechnologyLifeScale UpComplexReagentPharmaceutical PreparationsProductionPerformanceBindingBiologicalSamplingCross ReactivityPrototypeDetectionBloodLaboratoriesLiquid SubstanceDoseLibraries
Grant awards (40)
A novel peptide assay for hepcidin clinical monitoring$590,935
R44 · FY2024 · DK · contact PI
A novel peptide assay for hepcidin clinical monitoring$613,787
R44 · FY2023 · DK · contact PI
A Rapid Point of Care Test for APOL1 Renal Risk Alleles$741,371
R44 · FY2022 · MD · contact PI
Rapid assay to monitor vancomycin levels at the point of care in hemodialysis patients$682,788
R44 · FY2022 · DK · contact PI
Novel assay to monitor Tacrolimus levels at the point of care$735,018
R44 · FY2021 · AI · contact PI
A Rapid Point of Care Test for APOL1 Renal Risk Alleles$685,035
R44 · FY2021 · MD · contact PI
Rapid assay to monitor vancomycin levels at the point of care in hemodialysis patients$679,410
R44 · FY2021 · DK · contact PI
Development of a novel clinical assay for measuring everolimus levels$648,895
R44 · FY2021 · AI · contact PI
Novel assay to monitor Tacrolimus levels at the point of care$734,099
R44 · FY2020 · AI · contact PI
Development of a novel clinical assay for measuring everolimus levels$717,613
R44 · FY2020 · AI · contact PI
Rapid assay to monitor vancomycin levels at the point of care in hemodialysis patients$590,249
R44 · FY2020 · DK · contact PI
Immunoprofiling to develop a novel diagnostic array for cardiac sarcoidosis$299,802
R43 · FY2020 · HL · contact PI
Novel assay to monitor Tacrolimus levels at the point of care$759,336
R44 · FY2019 · AI · contact PI
Development of a novel clinical assay for measuring everolimus levels$744,006
R44 · FY2019 · AI · contact PI
Development of a multiplex peptide array to identify patients with an autoantibody signature for chronic pain$320,058
R43 · FY2019 · DA · contact PI
Rapid assay to monitor vancomycin levels at the point of care in hemodialysis patients$283,225
R44 · FY2019 · DK · contact PI
Stem cell-binding peptides for rapid fixation of total hip replacements$746,272
R44 · FY2018 · AR · contact PI
Novel assay to monitor Tacrolimus levels at the point of care$300,000
R44 · FY2018 · AI · contact PI
Stem cell-binding peptides for rapid fixation of total hip replacements$749,918
R44 · FY2017 · AR · contact PI
Phage-based assay to measure daptomycin concentration in biological fluids$671,292
R44 · FY2017 · GM · contact PI
Novel PhageLock assay to measure hepcidin for clinical monitoring$333,003
R43 · FY2017 · DK · contact PI
Peptide-based tool for the rapid isolation of quiescent monocytes from peripheral blood$308,839
R43 · FY2017 · CA · contact PI
Phage-based assay to measure daptomycin concentration in biological fluids$668,916
R44 · FY2016 · GM · contact PI
Peptide-based slides for improving the diagnostic quality of sputum specimens$299,999
R43 · FY2016 · CA · contact PI
Beta-2 Microglobulin Depletion Columns for Amyloidosis Prevention and Treatment$293,816
R43 · FY2015 · HL · contact PI
Phage-based assay to measure daptomycin concentration in biological fluids$256,978
R43 · FY2015 · GM · contact PI
Development of an adipose-derived stem cell isolation matrix$789,247
R44 · FY2014 · GM · contact PI
Peptide-mediated apheresis for inflammatory bowel diseases$280,768
R43 · FY2014 · DK · contact PI
Stem cell therapy for improved fixation of cementless total hip replacements$224,737
R43 · FY2014 · AR · contact PI
Development of an adipose-derived stem cell isolation matrix$1,025,971
R44 · FY2013 · GM · contact PI
Point of Care Adult Stem Cell Isolation$958,831
R44 · FY2012 · AR · contact PI
Development of an adipose-derived stem cell isolation matrix$807,976
R44 · FY2012 · GM · contact PI
Development of an adipose-derived stem cell isolation matrix$202,432
R44 · FY2012 · GM · contact PI
Novel coatings on titanium implants for the delivery of stem cells$149,771
R43 · FY2012 · DE · contact PI
Point of Care Adult Stem Cell Isolation$869,485
R44 · FY2011 · AR · contact PI
Growth Factor Coated Sutures for Improved Tendon Repair$446,003
R44 · FY2010 · AR · contact PI
Development of an adipose-derived stem cell isolation matrix$318,022
R43 · FY2010 · GM · contact PI
Point of Care Attachment of Antibiotics onto Metal Implants$1,016,586
R44 · FY2009 · AI · contact PI
Subgingival Drug Delivery for Periodontitis Prevention and Treatment$293,590
R43 · FY2009 · DE · contact PI
Prohealing Coatings for Cardiovascular Implants$297,258
R43 · FY2008 · HL · contact PI